Urelumab alone or in combination with rituximab in patients with relapsed or refractory B‐cell lymphoma - Timmerman, John; Herbaux, Charles; Ribrag, Vincent; Zelenetz, Andrew D.; Houot, Roch; Neelapu, Sattva S.; Logan, Theodore; Lossos, Izidore S.; Urba, Walter; Salles, Gilles; Ramchandren, Radhakrishnan; Jacobson, Caron; et al. (American journal of hematology, 2020)
Keywords: Antitumor activity; B-cell lymphoma; Cancer; CD137 antigen; Cytotoxicity; Disease control; Hematology; Hepatitis; Human health and pathology; Immunoglobulin G; Immunology; Immunotherapy; Life Sciences; Lymphoma; Monoclonal antibodies; Natural killer cells; Patients; Rituximab; Sepsis; Targeted cancer therapy